注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Allovir Inc是一家后期临床阶段的细胞治疗公司。该公司致力于开发用于治疗和预防病毒性疾病的同种异体T细胞疗法。其病毒特异性T细胞(VST)治疗平台能够生成VST,旨在恢复T细胞缺陷患者的免疫力。其候选产品包括posoleucel、ALVR106、ALVR109、ALVR107和ALVR108。其主要候选产品posoleucel是针对六种病毒的多VST疗法:BK病毒(BKV)、巨细胞病毒(CMV)、腺病毒(AdV)、Epstein-Barr病毒(EBV)、JC病毒(JCV)和人类疱疹病毒6(HHV-6)。ALVR106是一种同种异体VST疗法,旨在针对四种呼吸道病毒引起的疾病:呼吸道合胞病毒(RSV)、流感、副流感病毒(PIV)和人偏肺病毒(hMPV)。VST制造平台可重复生成单病毒和多病毒特异性细胞治疗候选药物。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Vikas Sinha | 59 | 2019 | President, CFO & Director |
Morana Jovan-Embiricos | 55 | 2019 | Independent Non-Executive Director |
Jeffrey S. Bornstein | 56 | 2020 | Independent Non-Executive Director |
David L. Hallal | 56 | 2018 | Executive Chairman of the Board |
Malcolm K. Brenner | 69 | 2012 | Independent Non-Executive Director |
Diana M. Brainard | 51 | 2020 | CEO & Director |
Juan F. Vera | 43 | 2014 | Non-Executive Director |
Shawn Cline Tomasello | 64 | 2022 | Independent Director |
Michael Boeckh | - | 2023 | Member of Scientific Advisory Board |
Gerard Socie | - | 2023 | Member of Scientific Advisory Board |
Anil K. Chandraker | - | 2023 | Member of Scientific Advisory Board |
John F. DiPersio | - | 2023 | Member of Scientific Advisory Board |
John W. Mellors | 85 | 2023 | Member of the Scientific Advisory Board |
Stella Davies | - | 2023 | Member of Scientific Advisory Board |
Derek Adams | 49 | 2023 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核